Gotu Kola: The Definitive Guide

What is gotu kola?

Gotu kola is Centella asiatica, also called Asian pennywort. It is not the same plant as bacopa, even though both may be sold under the name “brahmi.” Supplements use dried aerial parts, leaf powder, aqueous extracts, total triterpene fractions or products standardized to asiaticoside, madecassoside and related triterpenes. [1], [6]

Human research covers different questions: cognitive tests, mood, pharmacokinetics, exercise plus supplementation and chronic venous insufficiency. Results from one preparation cannot be assigned to another or to a multi-ingredient product.

The clearest cognitive synthesis found no strong evidence of improvement. The clearest safety signal is rare acute liver injury with jaundice, based on case reports rather than a known incidence. [1], [6]

Typical Gotu Kola Protocols

There is no RDA, AI or established UL for gotu kola. A research dose belongs to its exact extract, population and endpoint.

Titration

No validated self-titration is established. Assigned trial groups are not escalation steps.

Timing

The selected studies used once-daily, twice-daily or single-dose schedules. Evidence does not establish a best time or meal relationship.

Duration

Cognitive trials were generally short. Rare liver reports developed after roughly three to eight weeks, so duration is not a guarantee of safety. [6], [7]

Stopping

No taper is established. Stop and seek prompt assessment for jaundice, dark urine, severe fatigue, persistent nausea, itching or right-upper-abdominal pain.

What is gotu kola commonly used for?

People use gotu kola for memory, focus, anxiety, circulation, leg swelling, wound healing and skin health. Oral cognition and venous-insufficiency research should not be mixed with topical wound products.

The 2017 review included five randomized trials of Centella alone and six trials of Centella-containing products. Meta-analysis found no significant difference from placebo in cognitive domains. Acute alertness and anger signals were based on limited outcomes and do not establish durable mood treatment. [1]

The venous review included eight studies and reported possible improvements in edema, heaviness, pain and microcirculatory measures, but three studies lacked quantitative data and most were inadequately reported. [5]

Which form and label details matter?

Read the label in this order:

1. Species: Centella asiatica, not Bacopa monnieri.
2. Part: aerial parts, leaf or whole herb.
3. Preparation: powder, aqueous extract or total triterpene fraction.
4. Markers: asiaticoside, madecassoside, asiatic acid, madecassic acid or total triterpenes.
5. Actual amount and extract ratio: do not equate milligrams of concentrated extract with grams of herb.
6. Lot testing: identity, microbes, heavy metals, pesticides and undeclared ingredients.

“Brahmi,” “memory herb,” “tiger grass” and “standardized” are not enough to match a study. Multi-ingredient blends cannot show which ingredient produced an outcome.

What does the human evidence show?

Cognition and mood

Puttarak and colleagues found no significant improvement versus placebo across cognitive domains. Preparations, doses and tests varied, and some trials used multi-ingredient products. Acute alertness and anger results came from small data sets and do not prove a sustained mental-health benefit. [1]

The 28-person Wattanathorn study allocated healthy older adults to 250, 500 or 750 mg once daily for two months. Its small groups and multiple cognitive and mood outcomes limit dose-response conclusions. [2]

The later MCI study combined 500 mg twice daily with supervised resistance, aerobic, balance and dual-task exercise. Both exercise groups improved versus control, so the design does not isolate the supplement's added effect in the abstract. [4]

Pharmacokinetics are not cognitive efficacy

The 2022 phase I crossover study involved only four cognitively impaired older adults on cholinesterase inhibitors. Single 2 g and 4 g doses allowed measurement of triterpene metabolites and NRF2-related gene expression over 10 hours. The product was made for research, and the study was not designed to show memory or dementia benefit. [3]

Chronic venous insufficiency

The 2013 review found eight trials suggesting possible improvement in edema, leg symptoms and microcirculatory measures. Inadequate reporting, unclear risk of bias, missing quantitative data and preparation differences make the conclusion tentative. [5]

How might it work?

Centella contains triterpene glycosides and aglycones, including asiaticoside, madecassoside, asiatic acid and madecassic acid. Laboratory hypotheses involve extracellular-matrix signaling, oxidative-stress responses and neuronal pathways. [3], [6]

Detection of metabolites or NRF2 expression is target engagement, not proof of cognitive, vascular or wound benefit. Topical wound mechanisms do not establish an oral regimen.

What are the risks and interactions?

Small studies report mild nonspecific effects such as headache, dizziness, bloating, diarrhea and nausea. Topical allergy has also been reported. [6]

LiverTox links Centella to rare clinically apparent acute liver injury with jaundice and assigns likelihood score C, a probable rare cause. Published cases developed after about three to eight weeks and generally resolved after stopping; contamination or other hepatotoxins were not always excluded. Rechallenge should be avoided. [6], [7]

Evidence for medicine interactions is sparse. Sedating effects are sometimes reported, and liver disease or concurrent hepatotoxic medicines increase the importance of professional review. Cognitive impairment treated with cholinesterase inhibitors should not prompt extrapolation from the four-person phase I study.

Pregnancy, breastfeeding, pediatric use and long-term oral safety are inadequately characterized. These cautions apply in the United States and Canada, where legal sale does not prove benefit or liver safety.

Seek prompt care for yellow skin or eyes, dark urine, pale stool, persistent vomiting, severe fatigue, widespread rash, facial swelling, breathing difficulty, fainting or confusion.

Legal status in the United States and Canada

In the United States, gotu kola products are sold as dietary supplements and are not approved to treat cognitive impairment, dementia, venous disease or liver disease. [6]

In Canada, Centella asiatica appears in the traditional Chinese medicine ingredient framework, and licensed natural health products carry an NPN. A listing does not establish that every oral extract has the same evidence or safety. [8]

What should you monitor?

Record species, plant part, extract ratio, markers, amount, frequency, lot, start date and other medicines. Note nausea, diarrhea, dizziness, rash, unusual fatigue, itching, dark urine or jaundice.

Do not use repeated memory ratings as proof of efficacy. Cognitive complaints and leg swelling have multiple causes and deserve assessment rather than supplement-only tracking.

What happens when you stop?

No withdrawal syndrome or taper is established. Suspected liver injury requires prompt withdrawal and assessment; do not rechallenge after a likely Centella-related injury. [6]

How should it be stored?

Follow the label. Keep powders and extracts closed, dry, away from heat and children. Discard damp, moldy, damaged, expired or poorly identified products.

How does gotu kola compare with other approaches?

Exercise has direct benefits for function and health and should not be credited to gotu kola in a combined intervention. Compression and evaluation of the cause remain central for venous insufficiency. Cognitive complaints need assessment for reversible causes.

Bacopa is a different plant despite shared use of “brahmi.” Ginkgo, lion's mane and prescription cognitive medicines also have separate evidence and risks.

What do public communities add?

Public discussions can reveal name confusion, taste, sedation, digestive effects and stacking patterns. They cannot verify species, extract composition, cognition, circulation or liver safety. Feeling calmer or sharper does not establish a durable clinical benefit.

Common questions

Does gotu kola improve memory?

Strong evidence is absent. A 2017 systematic review found no significant improvement versus placebo across cognitive domains. [1]

Is gotu kola the same as bacopa?

No. Centella asiatica and Bacopa monnieri are different plants that may both be called brahmi.

Does gotu kola treat dementia?

No. The four-person phase I study measured pharmacokinetics and gene expression after single doses; it did not test dementia treatment. [3]

Does it help leg swelling?

Older, poorly reported trials suggest possible signals in chronic venous insufficiency, but the evidence is uncertain and preparation-specific. [5]

Can gotu kola injure the liver?

Rare acute liver injury with jaundice has been reported. Stop and seek assessment for liver symptoms; avoid rechallenge after suspected injury. [6], [7]

Is more effective than less?

No reliable dose-response has been established. Small assigned dose groups and phase I single doses are not proof that more works better.

Can it be combined with cognitive medicines?

Interaction evidence is inadequate. The phase I study in four people on cholinesterase inhibitors cannot establish general compatibility. [3]

Is it safe during pregnancy or breastfeeding?

Reliable oral safety data are lacking. Avoid self-directed use and seek professional advice.

Glossary

Terms used in this guide.

Centella asiatica

The botanical species commonly called gotu kola or Asian pennywort.

Triterpenes

A constituent class including asiaticoside, madecassoside and their aglycones.

Pharmacokinetics

How compounds are absorbed, distributed, metabolized and eliminated; it does not establish clinical benefit.

NRF2

A regulator of cellular stress-response genes measured as an exploratory marker in a four-person phase I study.

Chronic venous insufficiency

Impaired venous return in the legs that can cause swelling, heaviness, pain and skin changes.

Rechallenge

Restarting a product after suspected injury; it should be avoided after likely gotu-kola liver injury.

Titration

Changing an amount in planned steps. No general gotu kola self-titration is established.

How this guide was researched

This draft used a cognition systematic review, two primary cognition studies, a four-person phase I pharmacokinetic report, a venous-insufficiency review, LiverTox, the primary liver-injury case series and Canada's traditional ingredient framework. Searches covered species identity, extract form, cognition, exercise, venous outcomes, wound claims, liver injury and interactions.

Corrections to the legacy manuscript include replacing confident memory and anxiety claims with the null cognitive synthesis; separating combination exercise from an isolated supplement effect; keeping phase I biomarkers distinct from efficacy; qualifying venous evidence; and elevating rare liver injury and name confusion with bacopa. Evidence was refreshed October 9, 2026.

How this guide was made

The source ledger stores product, population, schedule, outcome, access level and limitations. Primary studies support numeric rows; reviews and official records frame certainty and safety. Draft status means scientific, French-parity, asset and rendered-page review remain separate gates.

Sources

Related guides